{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T08:44:29Z","timestamp":1780735469955,"version":"3.54.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T00:00:00Z","timestamp":1671494400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ajoc.2022.101782","type":"journal-article","created":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T05:57:38Z","timestamp":1671775058000},"page":"101782","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["IgG4-related disease presenting with profound bilateral orbital and adnexal inflammation"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5005-7249","authenticated-orcid":false,"given":"Anne E.","family":"Kutzscher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8069-4107","authenticated-orcid":false,"given":"Rona Z.","family":"Silkiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajoc.2022.101782_bib1","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1007\/s00535-003-1175-y","article-title":"A new clinicopathological entity of IgG4-related autoimmune disease","volume":"38","author":"Kamisawa","year":"2003","journal-title":"J Gastroenterol"},{"issue":"2","key":"10.1016\/j.ajoc.2022.101782_bib2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/IOP.0000000000000363","article-title":"IgG4-related ophthalmic disease. Part I: background and pathology","volume":"31","author":"McNab","year":"2015","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"3","key":"10.1016\/j.ajoc.2022.101782_bib3","doi-asserted-by":"crossref","DOI":"10.1097\/IOP.0000000000000364","article-title":"IgG4-Related ophthalmic disease. Part II: clinical aspects","volume":"31","author":"McNab","year":"2015","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"9","key":"10.1016\/j.ajoc.2022.101782_bib4","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","article-title":"Consensus statement on the pathology of IgG4-related disease","volume":"25","author":"Deshpande","year":"2012","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.ajoc.2022.101782_bib5","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13075-021-02432-y","article-title":"Needle biopsy compared with surgical biopsy: pitfalls of small biopsy in histological diagnosis of IgG4-related disease","volume":"23","author":"Liu","year":"2021","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.ajoc.2022.101782_bib6","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/14397595.2017.1290911","article-title":"Current approach to the diagnosis of IgG4-related disease - combination of comprehensive diagnostic and organ-specific criteria","volume":"27","author":"Umehara","year":"2017","journal-title":"Mod Rheumatol"},{"issue":"1","key":"10.1016\/j.ajoc.2022.101782_bib7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/art.41120","article-title":"The 2019 American college of rheumatology\/European league against rheumatism classification criteria for IgG4-related disease","volume":"72","author":"Wallace","year":"2020","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.ajoc.2022.101782_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10384-014-0352-2","article-title":"Japanese study group for IgG4-related ophthalmic disease. Diagnostic criteria for IgG4-related ophthalmic disease","volume":"59","author":"Goto","year":"2015","journal-title":"Jpn J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajoc.2022.101782_bib9","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/01676830.2017.1337192","article-title":"The impact of IgG-4-ROD on the diagnosis of orbital tumors: a retrospective analysis","volume":"36","author":"Andron","year":"2017","journal-title":"Orbit"},{"issue":"11","key":"10.1016\/j.ajoc.2022.101782_bib10","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1080\/02713683.2019.1627462","article-title":"IgG4-related ophthalmic disease in idiopathic sclerosing and non-sclerosing orbital inflammation: a 25-year experience","volume":"44","author":"Tsai","year":"2019","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.ajoc.2022.101782_bib11","article-title":"Pathologies associated with serum IgG4 elevation","volume":"2012","author":"Ebbo","year":"2012","journal-title":"Internet J Rheumatol"},{"key":"10.1016\/j.ajoc.2022.101782_bib12","article-title":"Spectrum of disorders associated with elevated serum IgG4 levels encountered in clinical practice","volume":"2012","author":"Ryu","year":"2012","journal-title":"Internet J Rheumatol"},{"issue":"1","key":"10.1016\/j.ajoc.2022.101782_bib13","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/annrheumdis-2013-204907","article-title":"The diagnostic utility of serum IgG4 concentrations in IgG4-related disease","volume":"74","author":"Carruthers","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.ajoc.2022.101782_bib14","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3324\/haematol.2018.205526","article-title":"IgG4-related disease: what a hematologist needs to know","volume":"104","author":"Chen","year":"2019","journal-title":"Haematol"},{"issue":"9","key":"10.1016\/j.ajoc.2022.101782_bib15","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.cgh.2017.02.007","article-title":"Increases in IgE, eosinophils, and mast cells can be used in diagnosis and to predict relapse of IgG4-related disease","volume":"15","author":"Culver","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.ajoc.2022.101782_bib16","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMra1104650","article-title":"IgG4-related disease","volume":"366","author":"Stone","year":"2012","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ajoc.2022.101782_bib17","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s13075-020-02338-1","article-title":"Serum IgE in the clinical features and disease outcomes of IgG4-related disease: a large retrospective cohort study","volume":"22","author":"Zhou","year":"2020","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1016\/j.ajoc.2022.101782_bib18","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/rheumatology\/kev438","article-title":"Predictors of disease relapse in IgG4-related disease following rituximab","volume":"55","author":"Wallace","year":"2016","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.ajoc.2022.101782_bib19","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/aos.14048","article-title":"The treatment outcomes in IgG4-related orbital disease: a systematic review of the literature","volume":"97","author":"Detiger","year":"2019","journal-title":"Acta Ophthalmol"},{"issue":"19","key":"10.1016\/j.ajoc.2022.101782_bib20","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.2169\/internalmedicine.0300-17","article-title":"Longstanding IgG4-related ophthalmic disease dramatically improved after steroid therapy","volume":"57","author":"Hirata","year":"2018","journal-title":"Intern Med"},{"issue":"1","key":"10.1016\/j.ajoc.2022.101782_bib21","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1186\/s40064-016-2537-2","article-title":"IgG4-related disease: a case report with duration of more than 16 years and review of literature","volume":"5","author":"Peng","year":"2016","journal-title":"SpringerPlus"},{"issue":"26","key":"10.1016\/j.ajoc.2022.101782_bib22","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004002","article-title":"Therapeutic approach to IgG4-related disease","volume":"95","author":"Brito-Zer\u00f3n","year":"2016","journal-title":"Medicine (Baltim)"},{"issue":"3","key":"10.1016\/j.ajoc.2022.101782_bib23","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s13311-022-01210-1","article-title":"Autoimmune neurological disorders with IgG4 antibodies: a distinct disease spectrum with unique IgG4 functions responding to anti-B cell therapies","volume":"19","author":"Dalakas","year":"2022","journal-title":"Neurotherapeutics"},{"issue":"12","key":"10.1016\/j.ajoc.2022.101782_bib24","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1136\/annrheumdis-2014-205799","article-title":"B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease","volume":"74","author":"Della-Torre","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.ajoc.2022.101782_bib25","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jaci.2020.07.016","article-title":"Targeting FcRn for immunomodulation: benefits, risks, and practical considerations","volume":"146","author":"Peter","year":"2020","journal-title":"J Allergy Clin Immunol"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S245199362200528X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S245199362200528X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,20]],"date-time":"2025-07-20T03:08:45Z","timestamp":1752980925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S245199362200528X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":25,"alternative-id":["S245199362200528X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2022.101782","relation":{},"ISSN":["2451-9936"],"issn-type":[{"value":"2451-9936","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IgG4-related disease presenting with profound bilateral orbital and adnexal inflammation","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2022.101782","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101782"}}